Aliskiren | Noden Pharma | ||
150,300 mg; Tablet, Oral |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
None | None | ||
Less Than 5
|
Less Than 5
|
||
Indicated for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure. | |||
Yes
|
Tekturna | Patent 1 | Patent 2 |
---|---|---|
******(***) | ******* | ******* |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
******(***) | *** \ *** | *** **, **** | ******* | ******** | ******** ** ***** **, **** |